Zenith Drugs (NSE:ZENITHDRUG) Interest Expense : ₹-20 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Zenith Drugs Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Zenith Drugs's interest expense for the six months ended in Mar. 2024 was ₹ -6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-20 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Zenith Drugs's Operating Income for the six months ended in Mar. 2024 was ₹ 64 Mil. Zenith Drugs's Interest Expense for the six months ended in Mar. 2024 was ₹ -6 Mil. Zenith Drugs's Interest Coverage for the quarter that ended in Mar. 2024 was 10.37. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zenith Drugs Interest Expense Historical Data

The historical data trend for Zenith Drugs's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Drugs Interest Expense Chart

Zenith Drugs Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Interest Expense

-14.04

-19.47

-11.48

-20.01

Zenith Drugs Semi-Annual Data
	Mar21	Mar22	Mar23	Sep23	Mar24
Interest Expense	-	-	-	-13.86	-6.15

Zenith Drugs Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-20 Mil.

Zenith Drugs (NSE:ZENITHDRUG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zenith Drugs's Interest Expense for the six months ended in Mar. 2024 was ₹-6 Mil. Its Operating Income for the six months ended in Mar. 2024 was ₹64 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2024 was ₹86 Mil.

Zenith Drugs's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	63.788	/	-6.154
	=	10.37

The higher the ratio, the stronger the company's financial strength is.

Zenith Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenith Drugs Ltd (NSE:ZENITHDRUG) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

K. No. 72 / 5, Village Muradpura, NA Depalpur, Indore, MP, IND, 453001

Website

https://www.zenithdrugs.com

Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules. It is also into Generic Medicines.

Zenith Drugs Headlines

No Headlines